Abstract:Background: Gambogic acid (GA) is a natural product from the resin of the Garcinia species, which showed significant activity in the induction of apoptosis. It can be one promising lead compound for the design and synthesis of new anticancer drugs. Objective: The objective of the current study is to design novel nitrogen-contained GA derivatives with better anti-cancer activities and study the effect of the introduction of different nitrogen-contained groups on the activity of GA. Methods: The designed 15 derivatives were synthesized via esterification or amidation of 30-carboxylate. The synthetic compounds were characterized via different spectroscopic techniques, including X-ray single crystal diffraction, MS and NMR. The cytotoxic activity of the designed derivatives was evaluated in vitro against A549, HepG-2, and MCF-7 cell lines using methyl thiazolyl tetrazolium (MTT) test. Results: 15 nitrogen-contained GA derivatives were successfully synthesized and established. Based on the IC50 values, compounds 9, 10, 11 and 13 showed stronger inhibitory effects on A549, HepG-2, MCF-7 cell lines than GA, while 9 is the most active compound with IC 50 value of 0.64-1.49 μM. Most derivatives of GA with esterification of C-30 including cyano-benzene ring were generally weaker than those of pyrimidinyl-substituted derivatives. In addition, length of alkyl linkers between C-30 of GA and nitrogen-contained group produced different effects on A549, HepG-2 and MCF-7 cell lines. Conclusion: The structure-activity relationship results show that aromatic substituent and linker length play important roles to improve the anticancer activities, while compound 9 with pyrimidine substituent and C-C-C linkers is the most active derivative against tested cell lines, and is a promising anti-cancer agent for further development.

Research Progress in the Field of Gambogic Acid and Its Derivatives as Antineoplastic Drugs

Gambogic Acid as a Candidate for Cancer Therapy: A Review

Design, Synthesis and Anti-cancer Evaluation of Nitrogen-containing Derivatives of 30-Carboxyl of Gambogic Acid

Synthesis and Biological Evaluation of Novel Spin Labeled 18Β-Glycyrrhetinic Acid Derivatives

Unveiling Gambogenic Acid as a Promising Antitumor Compound: A Review

Gambogic Acid-Loaded Biomimetic Nanoparticles in Colorectal Cancer Treatment.

Application of 18β-glycyrrhetinic acid in the structural modification of natural products: a review

Design, Synthesis, and Biological Evaluation of Gambogenic Acid Derivatives: Unraveling Their Anti-Cancer Effects by Inducing Pyroptosis.

Synthesis, Molecular Docking and Biological Evaluation of Glycyrrhizin Analogs As Anticancer Agents Targeting EGFR.

Design, synthesis and biological evaluation of novel o-aminobenzamide derivatives as potential anti-gastric cancer agents in vitro and in vivo

Gallic Acid: A Potential Anti-Cancer Agent

Enhancement of anticancer efficacy of chemotherapeutics by gambogic acid against gastric cancer cells.

Erythrocyte membrane encapsulated gambogic acid nanoparticles as a therapeutic for hepatocellular carcinoma

Andrographolide and its derivatives: Current achievements and future perspectives

Synthesis and Antiviral and Antitumor Activities of Novel 18β-Glycyrrhetinic Acid Derivatives

Design, Syntheses and Biological Evaluation of Natural Product Aiphanol Derivatives and Analogues: Discovery of Potent Anticancer Agents

Natural gambogic acid-tuned self-assembly of nanodrug towards synergistic chemophototherapy against breast cancer

Garcinia Xanthones As Orally Active Antitumor Agents

Anticancer activity and underlying mechanism of neogambogic acid

Proteomic and Bioinformatic Analyses of Possible Target-Related Proteins of Gambogic Acid in Human Breast Carcinoma MDA-MB-231 Cells.

Synthesis and in vitro/in vivo anticancer evaluation of pentacyclic triterpenoid derivatives linked with l-phenylalanine or l-proline